Reducing time to reperfusion for ST elevation myocardial infarction patients by a simple process change in the

Jill Byrne1

  • 1Belfast Health and Social care Trust.

Insights

Implementing a direct-to-ECG pathway significantly reduced First Medical Contact to Balloon (FMC-B) times for ST-elevation myocardial infarction (STEMI) patients. This bypasses triage, improving timely reperfusion therapy in non-percutaneous coronary intervention centers.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Healthcare Management

Background:

  • European Society of Cardiology (ESC) guidelines recommend First Medical Contact to Balloon (FMC-B) times under 120 minutes for ST-elevation myocardial infarction (STEMI).
  • Delays in FMC-B times are common, particularly at non-percutaneous intervention (PCI) capable hospitals.
  • Initial assessment delays, including registration to electrocardiogram (ECG) times, contribute to prolonged FMC-B in STEMI patients.

Purpose of the Study:

  • To evaluate the impact of a streamlined system on reducing FMC-B times in STEMI patients at a non-PCI capable hospital.
  • To assess the effectiveness of bypassing traditional triage for immediate ECG acquisition.

Main Methods:

  • A pre-intervention audit identified prolonged registration to ECG times due to undertriage and resource limitations.
  • A new protocol was implemented where chest pain patients bypassed triage for direct assessment in a dedicated investigation cubicle for immediate ECG.
  • ECG results guided immediate management decisions, either admission or return to waiting room if non-diagnostic.

Main Results:

  • Median FMC-B time decreased from 108.5 minutes (pre-intervention, n=21) to 82 minutes (post-intervention, n=17).
  • The intervention demonstrated a significant reduction in reperfusion delays.
  • The change was a simple, low-cost intervention.

Conclusions:

  • Bypassing triage for direct ECG acquisition is an effective strategy to reduce FMC-B times for STEMI patients.
  • This low-cost, transferable intervention can improve the quality of care at non-PCI capable sites.
  • Multidisciplinary collaboration and continuous audit are crucial for successful implementation and sustained improvement.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
443
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.6K
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.3K